Date of event
Thursday, February 25, 2021 - 5:00 pm -
Thursday, February 25, 2021 - 6:15 pm
Continuing Education Credits
Add to Calendar 2021-02-25 17:00:00 2021-02-25 18:15:00 Webinar: AASLD-ALEH COVID-19 and Liver Disease in the Americas: 2020 – 2021 and Beyond AASLD America/New_York public

Note: This webinar will be presented in Spanish only. / Este seminario web se presentará solo en español.

Content Contributor

  • American Association for the Study of Liver Diseases (AASLD)
  • Latin American Association for the Study of the Liver (Asociación Latinoamericana para el Estudio del Hígado; ALEH)
  • AASLD COVID-19 Task Force
  • AASLD COVID-19 Education & Outreach Subcommittee


  • Aldo Torre Delgadillo, MD, MSc
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador
  • Marina Serper, MD
    University of Pennsylvania Health System
  • Valeria Descalzi, MD
    Jefa de Hepatologia y Trasplante Hepático del Hospital Universitario Fundación Favaloro


  • Jorge A. Marrero, MD, FAASLD
    University of Texas Southwestern Medical Center
  • Manuel Mendizabal, MD
    Hospital Universitario Austral Buenos Aires


COVID-19 has not only had a profound impact on everyone around the world but also in how we practice hepatology and gastroenterology. In this webinar we will review how the Americas have adapted to the challenges that COVID-19 has presented and how different approaches to the treatment of COVID-19 has helped develop best practice in the following areas of hepatology during this pandemic:

  • Alcohol-associated Liver Disease
  • Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease
  • Liver Transplantation.

Presenter Bios

Marina Serper, MD

Marina Serper is Assistant Professor of Medicine at University of Pennsylvania Perelman School of Medicine and a physician at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. She is a transplant hepatologist and a clinical and applied health services investigator focused on the design of patient-oriented and health-system-based interventions to improve care in liver disease and liver transplantation. Her most recent research focuses on telemedicine and care redesign for advanced liver disease.

Photo of Dr. Marina Serper


Dra Valeria I. Descalzi

Training: Dra. Descalzi completed her undergraduate studies at the Faculty of Medicine, at the National University of Buenos Aires, obtaining the title of Physician in 1990. Within her postgraduate professional training, she completed a residency in Internal Medicine at the Center for Medical Studies and Clinical Investigations (CEMIC) obtaining the Certificate of Residence in Medical Clinic. She completed the Fellowship in Hepatology and Liver Transplantation in 1999 in the Liver Unit, Hepatobiliary Surgery and Liver Transplantation of the Favaloro Foundation (I.C. and C.C.)

Medical Assistance: She has worked as a clinical hepatologist in the Hepatology and Transplantation Unit of the Favaloro Foundation University Hospital since 1997, holding various positions during this period. She currently works as Head of Hepatology of the Hepatology and Liver Transplantation Unit of the Favaloro Foundation University Hospital.

Scientific Activity: Within the Professional and Academic Societies to which she belongs, she stands out being a Full Member of the Argentine Transplantation Society (SAT), The Transplantation Society (TTS), the Argentine Association for the Study of Liver Diseases (AAEEH). She has the title of Specialist in Hepatology granted by the Ministry of Health of the Nation and she works within the teaching area as Head of Practical Works Department of Internal Medicine, School of Medicine, Favaloro University. She has participated internationally in therapeutic clinical research trials and presented research developed within the field of hepatology and liver transplantation at both national and international conferences. Among the awards and mentions received, the "Adolfo Aztiria" Prize awarded by the National Academy of Medicine for the best work on clinical medicine stands out.

Work: "Natural History of Hepatitis C. Multidisciplinary Experience in Argentina." The Rolando Figueroa Barrios award granted by the ALEEH and also awarded by the AAEEH for the work "Evaluation of the use of Anti-HB core Positive Donors in Liver Transplantation in Argentina" and the Prize of the XXII Latin American and Caribbean Transplant Congress (STALYC) and XII Argentine Congress of Transplantation (SAT), for the study of the "Impact of Basiliximab therapy on the recurrence of hepatitis C after liver transplantation."

Photo of Dra Valeria I. Descalzi

Moderator Bio

Manuel Mendizabal, MD

Dr. Mendizabal currently works as a hepatologist at the Hepatology and Liver Transplantation Unit of the Austral University Hospital in Buenos Aires. He received his medical degree from Austral University and completed his Internal Medicine residency at the same Institution. He subsequently completed his training in Hepatology and Liver Transplantation at the University of Pennsylvania under the direction of Dr. Rajender Reddy. He is part of the different regional scientific societies, being currently the Secretary of the Latin American Association for the Study of the Liver (ALEH) and the Secretary of the Argentine Society for the Study of Liver (SAHE). His areas of interest are viral hepatitis, acute liver failure, and liver transplantation.

Photo of Manuel Mendizabal, MD